DVXV vs. XBI
DVXV (WEBs Health Care XLV Defined Volatility ETF) and XBI (SPDR S&P Biotech ETF) are both Health & Biotech Equities funds - DVXV tracks the Syntax Defined Volatility XLV Index while XBI tracks the S&P Biotechnology Select Industry Index. Both are passively managed. A 0.51 correlation means they provide meaningful diversification when combined. DVXV charges 0.89%/yr vs 0.35%/yr for XBI.
Performance
DVXV vs. XBI - Performance Comparison
Loading charts...
Returns By Period
In the year-to-date period, DVXV achieves a -3.39% return, which is significantly lower than XBI's 19.74% return.
DVXV
- 1D
- 0.86%
- 1M
- 0.61%
- YTD
- -3.39%
- 6M
- -4.00%
- 1Y
- —
- 3Y*
- —
- 5Y*
- —
- 10Y*
- —
XBI
- 1D
- 3.75%
- 1M
- 10.89%
- YTD
- 19.74%
- 6M
- 15.96%
- 1Y
- 77.88%
- 3Y*
- 19.92%
- 5Y*
- 1.79%
- 10Y*
- 11.06%
DVXV vs. XBI - Yearly Performance Comparison
| 2026 (YTD) | 2025 | |
|---|---|---|
DVXV WEBs Health Care XLV Defined Volatility ETF | -3.39% | 21.27% |
XBI SPDR S&P Biotech ETF | 19.74% | 41.09% |
Correlation
The correlation between DVXV and XBI is 0.51, which is moderate. They share some common price drivers but move independently often enough to provide real diversification benefit when combined.
| Correlation | |
|---|---|
Correlation (All Time) Calculated using the full available price history since Jul 23, 2025 | 0.51 |
Compare stocks, funds, or ETFs
Search for stocks, ETFs, and funds for a quick comparison or use the comparison tool for more options.
Return for Risk
DVXV vs. XBI — Risk / Return Rank
DVXV
Risk / return metrics aren't available yet — we need at least 12 months of trading data to calculate them.
XBI
DVXV vs. XBI - Risk-Adjusted Trends Comparison
This table presents a comparison of risk-adjusted performance metrics for WEBs Health Care XLV Defined Volatility ETF (DVXV) and SPDR S&P Biotech ETF (XBI). Risk-adjusted metrics are performance indicators that assess an investment's returns in relation to its risk, enabling a more accurate comparison of different investment options.
Values are calculated on a 1-year rolling basis and updated daily. Risk-adjusted metrics are more stable over longer periods — use the period switch above to explore them.
| DVXV | XBI | Difference | |
|---|---|---|---|
| Sharpe ratioReturn per unit of total volatility | — | — | |
| Sortino ratioReturn per unit of downside risk | — | — | |
| Omega ratioGain probability vs. loss probability | — | 1.46 | — |
| Calmar ratioReturn relative to maximum drawdown | — | 8.05 | — |
| Martin ratioReturn relative to average drawdown | — | 23.79 | — |
Loading charts...
Drawdowns
DVXV vs. XBI - Drawdown Comparison
The maximum DVXV drawdown since its inception was -14.36%, smaller than the maximum XBI drawdown of -63.89%. Use the drawdown chart below to compare losses from any high point for DVXV and XBI.
Loading charts...
Drawdown Indicators
| DVXV | XBI | Difference | |
|---|---|---|---|
Max DrawdownLargest peak-to-trough decline | -14.36% | -63.89% | +49.53% |
Max Drawdown (1Y)Largest decline over 1 year | — | -9.72% | — |
Max Drawdown (3Y)Largest decline over 3 years | — | -32.99% | — |
Max Drawdown (5Y)Largest decline over 5 years | — | -54.71% | — |
Max Drawdown (10Y)Largest decline over 10 years | — | -63.89% | — |
Current DrawdownCurrent decline from peak | -7.98% | -15.61% | +7.63% |
Average DrawdownAverage peak-to-trough decline | -4.86% | -20.93% | +16.07% |
Ulcer IndexDepth and duration of drawdowns from previous peaks | — | 3.28% | — |
Volatility
DVXV vs. XBI - Volatility Comparison
Loading charts...
Volatility by Period
| DVXV | XBI | Difference | |
|---|---|---|---|
Volatility (1M)Calculated over the trailing 1-month period | — | 9.97% | — |
Volatility (6M)Calculated over the trailing 6-month period | — | 21.32% | — |
Volatility (1Y)Calculated over the trailing 1-year period | 21.43% | 26.52% | -5.09% |
Volatility (5Y)Calculated over the trailing 5-year period, annualized | 21.43% | 32.30% | -10.87% |
Volatility (10Y)Calculated over the trailing 10-year period, annualized | 21.43% | 32.04% | -10.61% |
DVXV vs. XBI - Expense Ratio Comparison
DVXV has a 0.89% expense ratio, which is higher than XBI's 0.35% expense ratio.
Dividends
DVXV vs. XBI - Dividend Comparison
DVXV has not paid dividends to shareholders, while XBI's dividend yield for the trailing twelve months is around 0.40%.
| Position | TTM | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
DVXV WEBs Health Care XLV Defined Volatility ETF | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% |
XBI SPDR S&P Biotech ETF | 0.40% | 0.37% | 0.15% | 0.02% | 0.00% | 0.04% | 0.20% | 0.00% | 0.28% | 0.24% | 0.26% | 0.61% |
Frequently Asked Questions
DVXV and XBI have a correlation of 0.51, meaning they provide meaningful diversification benefit when combined. Depending on your allocation goals, holding both could reduce overall portfolio risk.
On fees, XBI is cheaper at 0.35% per year. The better choice depends on whether you care most about return, fees, risk, or income.
XBI is cheaper with a 0.35% expense ratio, compared with 0.89% for DVXV.
XBI has the higher dividend yield at 0.40%, compared with 0.00% for DVXV.
DVXV tracks Syntax Defined Volatility XLV Index, while XBI tracks S&P Biotechnology Select Industry Index. They also come from different issuers: WEBs and State Street. Their fees differ too: 0.89% for DVXV and 0.35% for XBI.
Find the right allocation for DVXV and XBI
Add both to a portfolio and optimize allocations for your target — whether that's maximizing returns, minimizing drawdowns, or balancing risk across holdings.
Open Portfolio Optimizer